Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and antiviral drugs. Its unique structure with both amino and hydroxyl groups, combined with the electron-withdrawing trifluoromethyl group, makes it valuable in enhancing metabolic stability and binding affinity in drug molecules. Commonly employed in the preparation of biologically active compounds where fluorine substitution improves pharmacokinetic properties. Also utilized in agrochemicals for designing novel active ingredients with improved efficacy and environmental profiles.